CSL (CSL) reports earnings on 12 Feb 2021 | wallmine AU
https://au.wallmine.com/asx/csl
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders ...
DA: 37 PA: 44 MOZ Rank: 5